ResearcherSichuan UniversityActive in the last 2 years
Jinlu Liu
Matched on ORCID iD 0000-0002-7781-7153; OpenAlex author ID A5066012800. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 2 papers
Papers 6
- Scoparone induces mitophagy and apoptosis via ROS accumulation in pancreatic cancer cells. Co-author DOI 10.1016/j.crtox.2026.100281↗
- Agrimol B inhibits pancreatic ductal adenocarcinoma by induction of lethal mitophagy through decreasing mitochondrial transcription termination factor 3. Co-author DOI 10.1093/pcmedi/pbag009↗
- tiRNA-Val-CAC-2 interacts with FUBP1 to promote pancreatic cancer metastasis by activating c‑MYC transcription. Co-author DOI 10.1038/s41388-024-02991-9↗
- Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment. Co-author DOI 10.3390/pharmaceutics15102421↗
- Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/jcm11113101↗
- Krüppel-like Factor 6 Suppresses the Progression of Pancreatic Cancer by Upregulating Activating Transcription Factor 3. Co-author DOI 10.3390/jcm12010200↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qing Zhu · 5 shared papers, 2022–2026 · strength 1.07
- Paper Agrimol B inhibits pancreatic ductal adenocarcinoma by induction of lethal mitophagy through decreasing mitochondrial t… DOI 10.1093/pcmedi/pbag009↗
- Paper Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment. DOI 10.3390/pharmaceutics15102421↗
- Paper tiRNA-Val-CAC-2 interacts with FUBP1 to promote pancreatic cancer metastasis by activating c‑MYC transcription. DOI 10.1038/s41388-024-02991-9↗
- Ningna Weng · 3 shared papers, 2022–2026 · strength 0.82
- Paper Scoparone induces mitophagy and apoptosis via ROS accumulation in pancreatic cancer cells. DOI 10.1016/j.crtox.2026.100281↗
- Paper Agrimol B inhibits pancreatic ductal adenocarcinoma by induction of lethal mitophagy through decreasing mitochondrial t… DOI 10.1093/pcmedi/pbag009↗
- Paper Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/jcm11113101↗
- Ying Zheng · 3 shared papers, 2022–2026 · strength 0.65
- Paper Agrimol B inhibits pancreatic ductal adenocarcinoma by induction of lethal mitophagy through decreasing mitochondrial t… DOI 10.1093/pcmedi/pbag009↗
- Paper tiRNA-Val-CAC-2 interacts with FUBP1 to promote pancreatic cancer metastasis by activating c‑MYC transcription. DOI 10.1038/s41388-024-02991-9↗
- Paper Krüppel-like Factor 6 Suppresses the Progression of Pancreatic Cancer by Upregulating Activating Transcription Factor 3. DOI 10.3390/jcm12010200↗
- Qunli Xiong · 3 shared papers, 2022–2024 · strength 0.49
- Paper tiRNA-Val-CAC-2 interacts with FUBP1 to promote pancreatic cancer metastasis by activating c‑MYC transcription. DOI 10.1038/s41388-024-02991-9↗
- Paper Krüppel-like Factor 6 Suppresses the Progression of Pancreatic Cancer by Upregulating Activating Transcription Factor 3. DOI 10.3390/jcm12010200↗
- Paper Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/jcm11113101↗
- Zhiwei Zhang · 3 shared papers, 2022–2024 · strength 0.49
- Paper tiRNA-Val-CAC-2 interacts with FUBP1 to promote pancreatic cancer metastasis by activating c‑MYC transcription. DOI 10.1038/s41388-024-02991-9↗
- Paper Krüppel-like Factor 6 Suppresses the Progression of Pancreatic Cancer by Upregulating Activating Transcription Factor 3. DOI 10.3390/jcm12010200↗
- Paper Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/jcm11113101↗
- Yongfeng Xu · 3 shared papers, 2022–2024 · strength 0.49
- Paper tiRNA-Val-CAC-2 interacts with FUBP1 to promote pancreatic cancer metastasis by activating c‑MYC transcription. DOI 10.1038/s41388-024-02991-9↗
- Paper Krüppel-like Factor 6 Suppresses the Progression of Pancreatic Cancer by Upregulating Activating Transcription Factor 3. DOI 10.3390/jcm12010200↗
- Paper Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/jcm11113101↗
- Sha Huang · 1 shared paper, 2026 · strength 0.36
- Yifei Ma · 1 shared paper, 2026 · strength 0.32
- Hong Zhu · 1 shared paper, 2023 · strength 0.26
- Zhu Zeng · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.